The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: How Informatics Can Assist the Secondary Use of Electronic Health Records to Inform Regulatory Decisions

Azadeh Shoaibi, Hui-Lee Wong, Christian Reich, Keran Moll, Tina Hernandez-Boussard. The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: How Informatics Can Assist the Secondary Use of Electronic Health Records to Inform Regulatory Decisions. In AMIA 2020, American Medical Informatics Association Annual Symposium, Virtual Event, USA, November 14-18, 2020. AMIA, 2020. [doi]

@inproceedings{ShoaibiWRMH20,
  title = {The Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: How Informatics Can Assist the Secondary Use of Electronic Health Records to Inform Regulatory Decisions},
  author = {Azadeh Shoaibi and Hui-Lee Wong and Christian Reich and Keran Moll and Tina Hernandez-Boussard},
  year = {2020},
  url = {http://knowledge.amia.org/72332-amia-1.4602255/t002-1.4606605/t002-1.4606606/3413651-1.4606622/3411272-1.4606619},
  researchr = {https://researchr.org/publication/ShoaibiWRMH20},
  cites = {0},
  citedby = {0},
  booktitle = {AMIA 2020, American Medical Informatics Association Annual Symposium, Virtual Event, USA, November 14-18, 2020},
  publisher = {AMIA},
}